Trademarkia Logo

Canada

C$
Trademark Search in Canada
MORPHOSYS

View On IC.GC.CA

MORPHOSYS
ADVERTISED

on 18 Dec 2024

Last Applicant/ Owned by

MorphoSys AG

Semmelweisstrasse 782152 Planegg

DE

Serial Number

2201869 filed on 22nd Mar 2022

Correspondent Address

FASKEN MARTINEAU DUMOULIN S.E.N.C.R.L., SRL

365, rue Abraham-Martinbureau 600Québec

QUEBEC

CA

G1K8N2

MORPHOSYS

Trademark usage description

chemical, biochemical, biological and biotechnological reagents for scientific and medical research for use in the research and production of small mo Read More

Classification Information

Class [001]
Chemical, biochemical, biological and biotechnological reagents for scientific and medical research for use in the research and production of small molecule pharmaceuticals; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products.

Classification kind code

11

Class [005]
Pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways; pharmaceutical preparations for epigenetic modulators as therapeutics; pharmaceuticals comprising small molecules for the treatment and prevention of metabolic disorders, autoimmune diseases, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; small molecule compounds for use as drug delivery agents in pharmaceuticals; small molecule pharmaceuticals being pharmaceuticals for the treatment and prevention of diseases and disorders, namely, metabolic disorders, autoimmune diseases, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis in humans; small molecule pharmaceuticals for the treatment of diseases and conditions, namely, metabolic disorders, autoimmune diseases, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, autoimmune diseases, Alzheimer's, sepsis, and restenosis; pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer, restenosis autoimmune diseases, and metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, and inflammatory diseases; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; diagnostic preparations for medical laboratory use, diagnostic preparations for medical purposes for detecting genetic predispositions, diagnostic preparations for medical purposes for detecting cancer, metabolic disorders, autoimmune diseases, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis and restenosis; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; clinical medical reagents for diagnostic use; biological preparations for medical purposes, namely, for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; pharmaceutical and veterinary preparations, agents and substances for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis.

Classification kind code

11

Class [042]
Research and development of pharmaceutical preparations, medicines and vaccines; providing medical and scientific research information in the field of pharmaceuticals; conducting clinical trials; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology.

Classification kind code

11

Mark Details

Serial Number

2201869

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 21st Mar 2024		Agent Changed
Submitted for opposition 20
on 21st Nov 2023		Examiner's First Report
Submitted for opposition 223
on 21st Nov 2023		Total Provisional Refusal
Submitted for opposition 22
on 20th Nov 2023		Search Recorded
Submitted for opposition 256
on 5th Jun 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 4th Aug 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 3rd Aug 2022		Created
Submitted for opposition 31
on 3rd Aug 2022		Formalized
Submitted for opposition 30
on 22nd Mar 2022		Filed
Submitted for opposition 228
on 22nd Mar 2022		International Registration